The largest trial to examine the impact of colchicine in acute myocardial infarction (MI) found that both acute and long-term ...

Introduction ST-elevation myocardial infarction (STEMI) is one of the most prevalent presentations in young patients. It is ...

Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the prevention of heart failure by reducing myocardial damage in acute ST-elevation myocardial infarction (STEMI) ...

Successful reperfusion following ST-segment elevation myocardial infarction ... However, only a minority of acute myocardial infarction (MI) patients present in such "ideal circumstances." ...

A 17-year analysis found sex-based differences in the prevalence and treatment of patients with ST-segment elevation MI with nonobstructive coronary arteries, but the mortality risk remains similar.

After a heart attack, aging adults face double or triple the risk of life-threatening complications – like a debilitating ...

For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...

Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

Patients: 475 patients with suspected acute ST elevation myocardial infarction treated before admission to hospital, 269 patients treated in hospital. Main outcome measures: Aborted myocardial ...

BACKGROUND: The optimal coronary stenting technique for true left main bifurcation lesions is uncertain. EBC MAIN (European ...